Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Mudcat who wrote (20835)	5/15/1998 8:25:00 AM
From: Tim Cruise	Read Replies (3) \| Respond to of 32384

If I may, I would like to jump in and express my opinion on how distasteful this Henry bashing is. I value Henry's contribution to this thread, and SI in general. He prompt posting of important news articles and commentary is genuinely appreciated by this investor. Have a good weekend, Tim

To: Mudcat who wrote (20835)	5/15/1998 8:37:00 AM
From: Henry Niman	Read Replies (2) \| Respond to of 32384

Actually, I don't think that I ever said the the H&Q price projection was the most accurate. I did indicate that it was quite a jump and I said that the $0.84 was not a typo. When I called me H&Q broker, I could not get any more info than what was printed - the estimate for 1999 was $0.84, the earnings were projected to be over $130 million, and the estimate was a new one (not a revision of a previous estimate). I also said that the number would be significant, regardless of the source, and speculated the number could come from off label sales as well as new deals. The new estimate of $0.11 did say that the revision was due in part to an increased number of shares due to the SRGN acquisition, but the reduced earnings estimate ($107 million) was not explained (and that number is markedly higher than 1998 projections). The new spot report did comment that the $0.11 was "in line" with others which is very true (Bear Stearns says $0.09 and Legg Mason says $0.08). The three estimates are remarkably close and all reflect a major improvement over losses projected for this year.